Breakthrough Pill Extends Pancreatic Cancer Survival
Global News Today | 2 Min News | The Daily News Now!
- Published
- May 31, 2026
- Duration
- 1:57
- Summary source
- description
- Last updated
- Jun 1, 2026
Discusses daily.
Summary
A breakthrough pill called daraxonrasib is giving advanced pancreatic cancer patients a fighting chance—doubling survival time and improving quality of life in a landmark study. Targeting a previously unreachable mutated protein, this drug outperformed chemotherapy, with patients living 13.2 months versus 6.7 months. Doctors were moved by the results, and…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
A breakthrough pill called daraxonrasib is giving advanced pancreatic cancer patients a fighting chance—doubling survival time and improving quality of life in a landmark study. Targeting a previously unreachable mutated protein, this drug outperformed chemotherapy, with patients living 13.2 months versus 6.7 months. Doctors were moved by the results, and regulators are fast-tracking approval. It could even open doors for earlier use and surgery eligibility—offering hope where there was once lit
Themes
- daily